Abstract Endometriosis is a continuous and progressive disease with a poorly understood aetiology, pathophysiology and natural history. This study evaluated the histological differences between eutopic and ectopic endometria (abdominal wall endometriosis) and the expression of mast cell proteases (tryptase and chymase), annexin A1 (ANXA1) and formyl peptide receptor 1 (FPR1). Ectopic endometrium from 18 women with abdominal wall endometriosis and eutopic endometrium from 10 women without endometriosis were obtained. The endometrial samples were analysed by histopathology, immunohistochemistry and ultrastructural immunogold labeling to determine mast cell heterogeneity (tryptase and chymase positive cells) and the expression levels of ANXA1 and FPR1. Histopathological analysis of the endometriotic lesions showed a glandular pattern of mixed differentiation and an undifferentiated morphology with a significant influx of inflammatory cells and a change in mast cell heterogeneity, as evidenced by a significant increase in the number of chymase-positive cells and endogenous chymase expression. The undifferentiated glandular pattern of endometriotic lesions was positively associated with a marked increase and co-localization of ANXA1 and FPR1 in the epithelial cells. In conclusion, the co-upregulated expression of mast cell chymase and ANXA1-FPR1 system in ectopic endometrium suggests their involvement in the development of endometriotic lesions.
Introduction
Endometriosis is a chronic inflammatory and multifactorial disease and represents a public health problem that affects 10-20 % of women in reproductive age. This disease often causes chronic pain and infertility (Podgaec et al. 2007; Burney 2013) . Endometriosis is characterised by the presence of endometrial-like tissue outside the uterine cavity. The endometrial implants are most commonly found in the pelvic cavity but can also be found in the ovaries, rectovaginal septum and occasionally in the pericardium, pleura, liver, kidney, bladder, and brain (Giudice and Kao 2004; Jiang and Wu 2012) . In some patients, these implants can proliferate in the abdominal wall or ovaries and develop into a benign tumour called endometrioma (Accetta et al. 2011; Ozel et al. 2012; Ding and Zhu 2013) .
The relationship between mast cells and endometriosis has been reported in the literature. Increased numbers of these cells have been found in the ectopic lesions (Konno et al. 2003; Fujiwara et al. 2004; Kempuraj et al. 2004; Sugamata et al. 2005; Menzies et al. 2011) . One of these studies revealed high numbers of activated mast cells in endometriosis sites that were strongly positive for corticotrophin-releasing hormone and urocortin both of which can activate mast cells and contribute to the fibrosis and inflammation in endometriosis (Kempuraj et al. 2004) .
In addition, the inflammatory response is controlled by anti-inflammatory mediators that maintain the homeostasis of the immune response and prevent tissue damage. Among these mediators we highlight annexin A1 (ANXA1), a 37 kDa protein with potent anti-inflammatory functions, expressed in different immune cells, particularly mast cells and neutrophils (Oliani et al. 2001; Gil et al. 2006; Gavins and Hickey 2012) . However, the relationship between ANXA1 and endometriosis is not well studied. One study described increased levels of ANXA1 protein and mRNA in the eutopic endometrium from patients with endometriosis without significant differences between proliferative and secretory phase (Li et al. 2008) . Furthermore, in this study, ANXA1 was detected in the peritoneal fluids of patients, suggesting a role of this protein in the pathogenesis of endometriosis.
The anti-inflammatory effects of ANXA1 are mediated through formyl peptide receptors (FPR), a family of G protein-coupled receptors (D'Acquisto et al. 2008; . Only three FPR types have been described in humans including FPR1, FPR2/ALX (also known as FPRL-1) and FPR3 (formerly designated as FPRL-2) . FPR expression occurs mainly in innate immune cells such as monocytes, macrophages, dendritic cells, neutrophils, hepatocytes and fibroblasts . One study reported the expression of FPR2/ALX in epithelial and stromal cells in the human endometrium (Macdonald et al. 2011 ). This group showed using RT-PCR that receptor upregulation correlated with the menstrual phase of the endometrial cycle and first trimester of pregnancy, indicating a role of FPR2/ALX in endometrium physiology.
Considering the complex and multifactorial pathogenesis of endometriosis, in this study, we focus one type and specific localization of this disease (abdominal wall endometrioma) to evaluate the expression of mast cell proteases and ANXA1-FPR system and correlate their functions with the development of this pathology.
Materials and methods

Patients
The patients in this study were included using the following criteria: age between 20 and 45 years, regular menstrual cycles, absence of hormone therapy within 3 months prior to consultation, and absence of autoimmune diseases confirmed by history and laboratory tests, when necessary. The patients were divided into the following two groups: women with abdominal wall endometriosis (n = 18) and women without the disease (control n = 10).
From July 2003 to January 2012, eighteen biopsies of abdominal wall endometrioma (ectopic endometrium), which were confirmed by histology, were provided by the Department of Pathology and Forensic Medicine, São José do Rio Preto School of Medicine (FAMERP), Brazil.
For the control group, ten eutopic endometrium samples were collected by hysteroscopy from patients without endometriosis as determined by clinical and physical examination or ultrasound. The samples were collected between June 2011 and July 2012 in the Division of Human Reproduction, Department of Gynaecology and Obstetrics (FAMERP), Brazil. The surgical procedure was carried out after obtaining written informed consent.
All samples were in the proliferative phase of the menstrual cycle, between the 8th and 12th day, and processed for paraffin embedding. Histopathology and quantitative analysis Eutopic (n = 10) and ectopic (n = 18) endometrium samples were fixed in 4 % buffered formalin for 24 h, washed in tap water, dehydrated in an ethanol series, and embedded in paraffin. Histopathology and quantitative analysis of inflammatory cells were performed on 4-lm sections of samples that were stained with haematoxylineosin and 0.5 % toluidine blue. Histological analysis of the ectopic tissues was performed using specific morphological classifications (Abrao et al. 2003) . In brief, the biopsies were classified as pure stromal, well-differentiated, undifferentiated, or mixed glandular.
Ethical approval
Mast cells (intact and degranulated) were evaluated in 4 lm tissue sections by visual inspection in a blind fashion and counted with a 40 9 objective on an Axioskop 2-Mot Plus Zeiss microscope (Carl Zeiss, Jena, Germany). Twenty-seven random fields in the eutopic and ectopic tissues were analysed per patient, and the area was determinted using AxioVision software. The values are reported as the mean ± standard error of the mean (SEM) of the number of cells per mm 2 . The same quantification method was used to analyse the number of tryptase and chymase positive mast cells.
Immunohistochemical studies
Mast cell tryptase and chymase expression
To better understand the mast cell heterogeneity in the eutopic and ectopic endometria, the expression of tryptase and chymase proteases was investigated in 4 lm sections of the paraffin embedded tissues. After an antigen retrieval step using citrate buffer (pH 6.0) at 96°C for 30 min, endogenous peroxide activity was blocked and the sections were incubated overnight at 4°C with the primary mouse monoclonal anti-chymase (1:100; Abcam, Cambridge, UK) and goat polyclonal anti-tryptase (1:200; Novocastra, UK) antibodies diluted in 2 % BSA. After washing, the sections were incubated with a secondary biotinylated antibody (Dako, Cambridge, UK). Positive staining was detected colourimetrically using a peroxidase conjugated streptavidin complex and DAB substrate (Dako, Cambridge, UK). The sections were counterstained with haematoxylin.
Quantification of tryptase and chymase-positive mast cells was performed in serial sections for each sample as described above. The values are reported as the mean ± SEM of number of the cells per mm 2 . Densitometric analyses for the protease immunostaining were performed in twenty mast cells per patient (n = 10/ group). The values were obtained as arbitrary units (a.u.) between 0 and 255 using AxioVision software on a ZeissAxioskop II light microscope. The data are expressed as the mean ± SEM.
ANXA1 and FPR expression
The detection of ANXA1 and FPR expression in the eutopic and ectopic tissues was performed according to a immunohistochemistry protocol using the primary rabbit polyclonal antibodies anti-ANXA1 (1:2,000) (Zymed Laboratories, Cambridge, UK), anti-FPR1 and anti-FPR2 (1:2,000 and 1:500, respectively; Abcam Cambridge, UK) diluted in 2 % BSA.
Densitometric analyses for the ANXA1 and FPR immunostaining were performed in the epithelial glandular tissue from eutopic (n = 10) and ectopic (n = 18) endometrium. The data are expressed as the mean ± SEM using arbitrary units (a.u.).
Postembedding immunogold labelling
To detect the co-localisation of endogenous ANXA1 protein with the FPR1 in epithelial cells, ultrathin Sections (90 nm) from eutopic and ectopic endometrium were incubated sequentially with the following reagents at room temperature: (i) distilled water; (ii) 0.1 mol/L phosphate buffer containing 1 % egg albumin (PBEA); (iii) 0.1 mol/L PBS containing 5 % egg albumin (PBEA) for 30 min; (iv) the sheep polyclonal antibody LPCS1 raised against ANXA1 (1:200 in PBEA) and rabbit polyclonal antibody FPR1 (1:100 in PBEA) for 2 h, with normal sheep and rabbit sera as controls (1:200); and (v) three washes (5 min each) in PBEA containing 0.01 % Tween 20. To detect ANXA1, a donkey anti-sheep IgG (Fc fragment-specific) antibody (1:100 in PBEA) conjugated to 10-nm colloidal gold (British Biocell, Cardiff, UK) was added. To detect FPR1, a goat anti-rabbit IgG (Fc fragment-specific) antibody (1:100 in PBEA) conjugated to 15 nm colloidal gold (British Biocell, Cardiff, UK) was added. After 1 h, the sections were washed extensively in PBEA containing 0.01 % Tween 20 and then in distilled water. These sections were stained with uranyl acetate and lead citrate and then examined using a ZEISS EM900 electron microscope (Department of Morphology and Genetics, UNIFESP).
Statistical analysis
The data were analysed using GraphPad software version 4.00. Significant differences between two groups were determined using Student's t test; more than two conditions were analysed by the Bonferroni test. In all cases, a probability value \0.05 was considered significant.
Results
Histopathological evaluation of eutopic and ectopic endometria
Histopathological analysis of the eutopic endometria from patients without endometriosis (control group; n = 10) revealed typical histological organisation of the mucosal layer of the uterus characterized by a simple columnar epithelium composed of nonciliated secretory columnar cells, ciliated cells, and a lamina propria (loose connective tissue) with straight tubular glands lined by columnar epithelium (Fig. 1a, b) . This glandular pattern confirmed that the fragments were collected in the proliferative phase.
The ectopic lesions (n = 18) showed two morphological patterns of endometriosis according to the histology classification proposed by Abrao et al. (2003) . The first was a glandular pattern of mixed differentiation (n = 11) characterised by the presence of an epithelial component composed of both endometrial-like cells (single columnar epithelium/well-differentiated glands) and undifferentiated cells (simple squamous or cubic epithelium) in the same fragment (Fig. 1c, d ). The second was an undifferentiated glandular pattern (n = 7) with the presence of epithelium forming glandular cystic spaces consisting of flattened or low cuboidal cells. These lesions contained a higher influx of innate immune cells, especially lymphocytes, neutrophils and mast cells, in the stroma and lumen of undifferentiated glands (Fig. 1c, d ) compared to the eutopic endometrium (Fig. 1a, b) . These results indicate that an inflammatory process is associated with this pathology.
The mast cell population increases and displays changes in protease expression in the endometrioma
The mast cell population was analysed in the eutopic and ectopic samples by staining with toluidine blue to assess metachromasia in the cytoplasmic granules. A significant increase in the number of metachromatic mast cells in the ectopic endometria was observed compared to the eutopic samples (Table 1 ). In addition, morphological study of the mast cells revealed a significant increase in the intact and degranulated cells in the ectopic samples compared to the control group (Table 1) .
The increased number of mast cells in the ectopic lesions prompted us to investigate whether there was a change in mast cell heterogeneity. To do this, we evaluated chymase and tryptase expression. Immunohistochemical staining revealed that the eutopic and ectopic endometria contained tryptase-and chymase-positive cells located in the stroma and next to the endometrial glands ( Fig. 2a-d ). An analysis of serial and subsequent sections of the eutopic endometrium demonstrated high numbers of tryptasepositive cells compared to chymase-positive cells (Fig. 2a,  b) , whereas in the ectopic tissues, this predominance was not evident (Fig. 2d, e) . This morphological observation was confirmed by measuring the density of the mast cells (Fig. 2c) . There was a significant increase in chymasepositive cells in the ectopic endometrium compared to eutopic, but no difference was found in the tryptase-positive cell population (Fig. 2c) .
Densitometric analysis of the mast cell proteases revealed no differences in tryptase levels in the The data represent the mean ± S.E.M. of the number of cells per mm 2 observed in 27 fields of the endometrium biopsies per patient (eutopic, n = 10; ectopic, n = 18) * P \ 0.05; *** P \ 0.001 versus eutopic (control) cytoplasmic granules of the cells in the eutopic and ectopic endometria (Fig. 2f) . On the other hand, the expression of chymase was significantly higher in the mast cells from the ectopic lesions compared to the cells from the eutopic lesions (Fig. 2f) .
The expression of ANXA1-FPR1 system is upregulated in endometrioma Because we found that endometrioma was associated with an increased mast cell population with changing heterogeneity, we next investigated the expression pattern of ANXA1, a potent anti-inflammatory protein that is expressed in mast cells (Oliani et al. 2000; Polli-Lopes et al. 2013 ). In the eutopic and ectopic samples, ANXA1 immunostaining was detected in the epithelial cells, with intense immunoreactivity in ciliated, endothelial and stromal cells and neutrophils (Fig. 3a, b) . Mast cells in the endometrium were also positive for ANXA1 (Fig. 3c, d) , and this was confirmed by analysing serial sections of biopsies stained with toluidine blue (Fig. 3e, f) .
In addition, to better understand ANXA1-FPR system in endometrium we performed immunohistochemical staining for FPR1 and FPR2. The eutopic and ectopic endometria To directly evaluate the relationship between ANXA1-FPR1 system expression and the change in the glandular pattern of endometriosis, we performed immunohistochemistry and ultrastructural immunocytochemistry. The epithelial gland cells from the eutopic and ectopic welldifferentiated glands showed similar patterns of ANXA1 (Fig. 4a, b) and FPR1 (Fig. 4d, e) expression. In contrast, undifferentiated glands (ectopic) demonstrated high immunoreactivity for ANXA1 (Fig. 4c) and FPR1 (Fig. 4f) compared to the eutopic and ectopic well-differentiated glands (Fig. 4a, b, d, e) . There was no immunostaining in the endometrium used as a negative control (Fig. 4g) . Densitometric analysis revealed a significant increase in the endogenous levels of ANXA1 (Fig. 4h) and FPR1 (Fig. 4i ) expression in the undifferentiated glands compared to the eutopic and ectopic well-differentiated glands, confirming the morphological observations. Ultrastructural analysis showed a similar pattern of ANXA1 and FPR1 expression in the epithelial gland cells of eutopic and ectopic samples. The expression was localised in the cytoplasm and plasma membrane, with some points of co-localisation (Fig. 5) .
Discussion
In the present study, we report a morphological alteration in the endometriotic lesions from abdominal wall endometrioma associated with inflammatory response characterized by increased inflammatory cell influx. The development of lesions was associated with a change in mast cell heterogeneity, as well as a marked increase in the endogenous levels of chymase. In addition, the undifferentiated glandular pattern of endometriotic lesions was positively associated with a marked increase and colocalization of ANXA1 and FPR1 in the epithelial cells. In our study, histological analysis of 18 ectopic endometrium biopsies revealed two morphological glandular patterns: undifferentiated and mixed, indicating abdominal wall endometrioma in the most advanced stage of endometriosis according previous study (Abrao et al. 2003) . Another investigation analysing 271 biopsies from 176 patients indicated a predominance of undifferentiated and mixed glandular patterns in deep endometriosis biopsies (33.5 and 46.9 %, respectively) and endometrioma (40.5 and 37.8 %), while the differentiated glandular pattern (41, 8 %) was common in superficial endometriotic lesions. These results suggest a correlation between the undifferentiated glandular pattern and severity of disease (Kamergorodsky et al. 2009 ).
Quantitative analysis of the mast cells revealed an increased number of intact and degranulated cells in the ectopic endometrium compared to the eutopic (control). These cells were localised near the glands and blood vessels in the ectopic endometrium stroma and generally degranulated. Consistent with our study, degranulated mast cells have also been reported in other studies of endometriosis (Kempuraj et al. 2004; Fujiwara et al. 2004 ; Sugamata et al. 2005) . In addition, in a study using an experimental model of endometriosis, rats treated with an antagonist of the leukotriene receptor showed a significant inhibition of infiltration and activation of mast cells in the endometrial lesions (Ihara et al. 2004) . Lesions of deeply infiltrating endometriosis and generally associated with pelvic pain and exhibit a high number of activated mast cells next to the peripheral nerves compared to observations in peritoneal and ovarian endometriosis (Anaf et al. 2006) . These data suggest a role of mast cells in the development of fibrosis, adhesion processes of endometriosis and the production of pain.
In this scenario, we evaluated the expression of tryptase and chymase in mast cells from eutopic and ectopic endometria to investigate mast cell heterogeneity. Quantitative analysis revealed that in eutopic samples, there was a predominance of tryptase-positive mast cells (MC T ) compared to the chymase-positive subpopulation. These results are in agreement with studies that detected a predominance of the MC T subpopulation in the functional layer of the endometrium in 107 eutopic endometrium biopsies from women without endometriosis or leiomyoma and who did not have hormone treatment for 1 year (Jeziorska et al. 1995) . On the other hand, there was a significant increase in chymase-positive cells in the ectopic endometria compared to the eutopic endometria, suggesting a change in the pattern of mast cell subtypes that are associated with lesions. Densitometric analysis revealed increased endogenous level of chymase, but not tryptase, in the cytoplasmic granules of mast cells from the ectopic endometrium. Similar results were reported in a study involving five types of endometriosis (peritoneal, ovarian, uterosacral ligaments, utero-vaginal septum, and bowel), which showed a significant increase in the chymase-positive mast cell subpopulation (Anaf et al. 2006 ). This same study showed elevated numbers of tryptase-positive mast cells in the lesions, except in ectopic tissues localised in the peritoneum and uterosacral ligament, compared to the tissues from regions not affected by endometriosis (controls). These data suggest that changes in the heterogeneity of mast cells are dependent on the type and localisation of endometriosis.
Because chymase is the first protease expressed in mast cells during maturation (Ma et al. 2008; Pejler et al. 2010) , the detection of high numbers of chymase-positive cells indicates a predominance of immature cells in the different types of endometriosis. In addition to tryptase and chymase proteases, mast cells also express ANXA1, a potent antiinflammatory protein, which has not been well studied in the endometriosis. This finding corroborates the literature (Oliani et al. 2000; Gil et al. 2006; Sena et al. 2006; PolliLopes et al. 2013 ) and reveals mast cells as important sources of ANXA1 in the tissue.
Our immunohistochemical studies further detected ANXA1 in stromal and epithelial gland cells, with high immunoreactivity in the ciliated epithelial cells of the uterine mucosa in both the eutopic and ectopic samples. These results are similar to proteomic studies performed by western blotting and immunohistochemistry, which revealed ANXA1 as a component of the ciliary axoneme in human (Rodrigo Tapia et al. 2004; Ostrowski et al. 2002) , bovine (Vishwanatha et al. 1995) and rabbit (Mayran et al. 1996) epithelial cells from the respiratory mucosa. In the female genital system, high expression of ANXA1 was detected in the placenta, ovaries, and uterus of pregnant rabbits compared to organs in the nonpregnant phase (Tsao et al. 1995) . In the human uterine mucosa, RT-PCR and western blotting analysis indicated that ANXA1 mRNA and endogenous protein levels were not affected by the menstrual cycle but were elevated in the eutopic endometrium of patients with endometriosis compared to patients without the disease (Li et al. 2008) .
Our immunohistochemical and densitometric analyses detected increased ANXA1 expression in undifferentiated epithelial glands in the ectopic samples compared to the endometrial glands (control-eutopic) and differentiated glands in the ectopic endometrium. This difference was also reported in the eutopic endometrium from patients with stages II-IV endometriosis (according to ASRM). The endometrial from these patients also displayed high immunoreactivity for ANXA1 in the epithelial gland cells compared to the eutopic endometrium from patients without endometriosis (Li et al. 2008) . Most studies indicate a proliferative role for endogenous ANXA1 in epithelial cells (Mulla et al. 2004 ); (Bai et al. 2004 ) that activates the mitosis cascade through cyclin D1 using the FPR1 and FPR2 receptors (Khau et al. 2011) .
Based on these data and the fact that few studies have investigated the expression of FPRs in the human endometrium, the next step of our study was to correlate the ANXA1 and FPR with the development of endometrioma.
Immunohistochemical and ultrastructural immunogold labelling analysis demonstrated for the first time in the human endometrium that FPR1 expression occurred in the same regions as ANXA1 expression. The eutopic and ectopic endometrial had similar immunoreactivity to FPR1, particularly in the inflammatory, stromal and endothelial cells. However, a significant increase in receptor and ANXA1 expression occurred in the undifferentiated glands from the ectopic endometrium compared to the other gland patterns (normal-eutopic; well-differentiated-ectopic).
In summary, our results show that abdominal wall endometrioma exhibits changes in both the stroma and epithelium tissue compartments. Inflammatory cell influx and changes in mast cells that modulate the endogenous levels of chymase, a potent pro-inflammatory mediator, occur in the stroma. In the epithelium, the high levels of ANXA1 and FPR1 correlate with morphological alterations in this tissue, which may participate in cell differentiation and proliferation.
